DESCRIPTION: Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for major depressive disorder (MDD) in children and adolescents. METHODS: The USPSTF reviewed the evidence on the benefits and harms of screening; the accuracy of primary care-feasible screening tests; and the benefits and harms of treatment with psychotherapy, medications, and collaborative care models in patients aged 7 to 18 years. POPULATION: This recommendation applies to children and adolescents aged 18 years or younger who do not have a diagnosis of MDD. RECOMMENDATION: The USPSTF recommends screening for MDD in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children aged 11 years or younger. (I statement).
DESCRIPTION: Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for major depressive disorder (MDD) in children and adolescents. METHODS: The USPSTF reviewed the evidence on the benefits and harms of screening; the accuracy of primary care-feasible screening tests; and the benefits and harms of treatment with psychotherapy, medications, and collaborative care models in patients aged 7 to 18 years. POPULATION: This recommendation applies to children and adolescents aged 18 years or younger who do not have a diagnosis of MDD. RECOMMENDATION: The USPSTF recommends screening for MDD in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children aged 11 years or younger. (I statement).
Authors: M J M Chinapaw; C B Terwee; L H Klaufus; M A J Luijten; E Verlinden; M F van der Wal; L Haverman; P Cuijpers Journal: Qual Life Res Date: 2021-05-13 Impact factor: 4.147
Authors: Frances L Lynch; John F Dickerson; Gregory N Clarke; William R Beardslee; V Robin Weersing; Tracy R G Gladstone; Giovanna Porta; David A Brent; Tami L Mark; Lynn L DeBar; Steven D Hollon; Judy Garber Journal: Psychiatr Serv Date: 2019-01-03 Impact factor: 3.084
Authors: Michael L Rinke; Hardeep Singh; Moonseong Heo; Jason S Adelman; Heather C O'Donnell; Steven J Choi; Amanda Norton; Ruth E K Stein; Tammy M Brady; Christoph U Lehmann; Steven W Kairys; Elizabeth Rice-Conboy; Keri Thiessen; David G Bundy Journal: Acad Pediatr Date: 2017-08-10 Impact factor: 3.107
Authors: Matthew C Aalsma; Ashley M Zerr; Dillon J Etter; Fangqian Ouyang; Amy Lewis Gilbert; Rebekah L Williams; James A Hall; Stephen M Downs Journal: J Adolesc Health Date: 2017-11-23 Impact factor: 5.012
Authors: Marisa E Hilliard; Maartje De Wit; Rachel M Wasserman; Ashley M Butler; Meredyth Evans; Jill Weissberg-Benchell; Barbara J Anderson Journal: Pediatr Diabetes Date: 2017-09-22 Impact factor: 4.866
Authors: Sally M Weinstein; Oksana Pugach; Genesis Rosales; Giselle S Mosnaim; Surrey M Walton; Molly A Martin Journal: Pediatrics Date: 2019-07-09 Impact factor: 7.124
Authors: Michelle Roseman; Nazanin Saadat; Kira E Riehm; Lorie A Kloda; Jill Boruff; Abel Ickowicz; Franziska Baltzer; Laurence Y Katz; Scott B Patten; Cécile Rousseau; Brett D Thombs Journal: Can J Psychiatry Date: 2017-08-29 Impact factor: 4.356
Authors: Tamara E Lewis Johnson; Camille A Clare; Jennifer E Johnson; Melissa A Simon Journal: J Womens Health (Larchmt) Date: 2020-07-30 Impact factor: 2.681